Negative symptoms due to sleep apnea syndrome in a patient with a delusional disorder.
Bottlender
R
R
Möller
H J
HJ
D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003702:Delusions / Q000150:complications* / Q000175:diagnosis*; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D017374:Paroxetine / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D018967:Risperidone / Q000627:therapeutic use; D012720:Severity of Illness Index; D012891:Sleep Apnea Syndromes / Q000150:complications*
D018687:Antidepressive Agents, Second-Generation; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D017374:Paroxetine; D006220:Haloperidol; D018967:Risperidone